Clinical Trial Update: Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating the safety and efficacy of bone marrow mononuclear cells (BMMNC) for Duchenne muscular dystrophy in Phase 1/2, sponsored by C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy
• Muscular Dystrophy

Drugs mentioned

• Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Muscular Dystrophy, Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: UNKNOWN